The 47 rating InvestorsObserver gives to Cara Therapeutics Inc (CARA) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 50 percent of stocks in the Biotechnology industry, CARA’s 47 overall rating means the stock scores better than 47 percent of all stocks.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Cara Therapeutics Inc Stock Today?
Cara Therapeutics Inc (CARA) stock is trading at $15.48 as of 1:09 PM on Monday, Sep 14, an increase of $0.57, or 3.82% from the previous closing price of $14.91. The stock has traded between $14.96 and $15.48 so far today. Volume today is 308,112 compared to average volume of 341,120.
Click Here to get the full Stock Score Report on Cara Therapeutics Inc (CARA) Stock.
